Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Akt2 relaxes podocytes in chronic kidney disease

A signaling cascade is activated in podocytes to induce survival and cope with stress during advanced glomerular disease, a new study shows. The findings may also explain why the immunosuppressor sirolimus, an inhibitor of this pathway, can cause proteinuria in a subset of patients with chronic kidney disease (pages 1288–1296).

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Podocyte function under conditions of nephron reduction.

Marina Corral Spence


  1. Reiser, J. & Sever, S. Annu. Rev. Med. 64, 357–366 (2013).

    Article  CAS  Google Scholar 

  2. Canaud, G. et al. Nat. Med. 19, 1288–1296 (2013).

    Article  CAS  Google Scholar 

  3. Wei, C. et al. Nat. Med. 14, 55–63 (2008).

    Article  CAS  Google Scholar 

  4. Nagase, M. & Fujita, T. Nat. Rev. Nephrol. 9, 86–98 (2013).

    Article  CAS  Google Scholar 

  5. Sarbassov, D.D. et al. Mol. Cell 22, 159–168 (2006).

    Article  CAS  Google Scholar 

  6. Laplante, M. & Sabatini, D.M. Cell 149, 274–293 (2012).

    Article  CAS  Google Scholar 

  7. Huber, T.B. et al. Mol. Cell Biol. 23, 4917–4928 (2003).

    Article  CAS  Google Scholar 

  8. Nozaki, S. et al. Cell Signal. 25, 1361–1371 (2013).

    Article  CAS  Google Scholar 

  9. Diekmann, F. et al. Transplant. Rev. (Orlando) 26, 27–29 (2012).

    Article  Google Scholar 

  10. Gödel, M. et al. J. Clin. Invest. 121, 2197–2209 (2011).

    Article  Google Scholar 

  11. Kistler, A.D. et al. Kidney Int. 81, 1053–1055 (2012).

    Article  CAS  Google Scholar 

  12. Yaddanapudi, S. et al. J. Clin. Invest. 121, 3965–3980 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jochen Reiser.

Ethics declarations

Competing interests

J.R. is an inventor on issued and pending patents on new mechanisms and technologies for proteinuric kidney diseases. He stands to gain royalties from the commercialization of these technologies.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Reiser, J. Akt2 relaxes podocytes in chronic kidney disease. Nat Med 19, 1212–1213 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing